(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 214.24%68.34M | 411.49%80.1M | 28.16%88.61M | 28.16%88.61M | 74.41%40.44M | 85.62%21.75M | -22.18%15.66M | 316.51%69.14M | 316.51%69.14M | 54.36%23.19M |
-Cash and cash equivalents | 214.24%68.34M | 411.49%80.1M | 28.16%88.61M | 28.16%88.61M | 74.41%40.44M | 85.62%21.75M | -22.18%15.66M | 316.51%69.14M | 316.51%69.14M | 54.36%23.19M |
-Accounts receivable | 82.05%122.09M | 51.94%120.49M | 12.51%81.94M | 12.51%81.94M | -16.31%62.78M | 14.18%67.06M | 59.36%79.3M | 13.73%72.83M | 13.73%72.83M | 12.93%75.02M |
Holding assets for sale | 1,132.11%10.71M | 237.00%1.26M | 19.96%1.34M | 19.96%1.34M | 30.47%501K | 1,920.93%869K | 26.87%373K | 69.24%1.12M | 69.24%1.12M | -46.89%384K |
Total current assets | 75.20%311.72M | 72.77%312.5M | 28.15%295.2M | 28.15%295.2M | 11.68%197.66M | 26.46%177.92M | 22.65%180.88M | 56.52%230.36M | 56.52%230.36M | 19.13%176.99M |
Non current assets | ||||||||||
-Accumulated depreciation | -12.77%-453.85M | -12.23%-442.25M | -9.29%-423.35M | -9.29%-423.35M | -10.98%-413.93M | -11.43%-402.46M | -11.47%-394.06M | -14.09%-387.36M | -14.09%-387.36M | -12.47%-372.97M |
-Long term equity investment | 84.76%704.86M | 82.91%667.82M | 59.31%622.62M | 59.31%622.62M | 1.70%404.41M | 3.69%381.5M | 0.54%365.1M | 12.57%390.83M | 12.57%390.83M | 3.11%397.66M |
Financial assets | ---- | ---- | -70.57%229K | -70.57%229K | ---- | ---- | ---- | --778K | --778K | ---- |
Non current note receivables | ---- | ---- | --0 | --0 | -24.06%284K | -79.41%77K | --0 | --387K | --387K | --374K |
-Goodwill | 30.12%8.07M | 15.49%7.61M | 2.47%7.5M | 2.47%7.5M | -16.50%5.88M | -6.30%6.2M | 14.11%6.59M | 66.01%7.32M | 66.01%7.32M | 76.60%7.04M |
Regulatory assets | 73.36%155.34M | 51.23%154.33M | 33.40%132.88M | 33.40%132.88M | -6.19%92.05M | 16.27%89.6M | 49.17%102.04M | 26.82%99.61M | 26.82%99.61M | 27.54%98.13M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 111.57%93.63M | 89.67%86.07M | 111.93%94.44M | 111.93%94.44M | -8.23%41.12M | -6.65%44.26M | -6.21%45.38M | -7.26%44.56M | -7.26%44.56M | -9.08%44.81M |
-Current debt | 117.31%91.96M | 96.59%84.18M | 120.23%92.69M | 120.23%92.69M | 91.45%39.36M | 105.68%42.32M | 115.22%42.82M | 113.73%42.09M | 113.73%42.09M | 5.20%20.56M |
-Current capital lease obligation | -13.78%1.67M | -26.16%1.89M | -29.47%1.74M | -29.47%1.74M | -92.72%1.77M | -92.78%1.94M | -91.01%2.56M | -91.29%2.47M | -91.29%2.47M | -18.46%24.26M |
-accounts payable | 47.93%119.74M | 52.40%124.02M | 42.56%146.19M | 42.56%146.19M | -10.51%76.17M | 9.91%80.95M | 25.07%81.38M | 34.49%102.55M | 34.49%102.55M | 20.24%85.12M |
-Total tax payable | 93.77%942.24M | 96.11%914.05M | 79.89%865.8M | 79.89%865.8M | 5.85%511.05M | 8.00%486.26M | 3.42%466.08M | 11.99%481.29M | 11.99%481.29M | 3.58%482.78M |
-Dividends payable | ---- | ---- | 27.45%2.67M | 27.45%2.67M | ---- | ---- | ---- | 84.52%2.1M | 84.52%2.1M | ---- |
-Other payable | -16.42%5.67M | -25.55%6.02M | ---- | ---- | 330.36%11.2M | 43.44%6.78M | 0.75%8.08M | ---- | ---- | -64.62%2.6M |
Current accrued expenses | 145.76%57.1M | 98.69%61.5M | 61.66%54.15M | 61.66%54.15M | 74.99%41.02M | 19.15%23.23M | 30.00%30.95M | 23.21%33.5M | 23.21%33.5M | -1.65%23.44M |
Current deferred liabilities | --9K | 34,050.00%1.37M | -95.82%59K | -95.82%59K | -56.05%69K | --0 | -99.76%4K | -57.87%1.41M | -57.87%1.41M | -91.70%157K |
Current liabilities | 104.02%302.83M | 90.35%300.21M | 68.50%324.02M | 68.50%324.02M | 3.16%158.38M | 5.22%148.44M | 13.54%157.71M | 19.42%192.3M | 19.42%192.3M | 5.30%153.53M |
Non current liabilities | ||||||||||
-Long term debt | 8.02%12.71M | 3.90%12.87M | -8.64%11.31M | -8.64%11.31M | -65.83%11.76M | -70.18%11.76M | -70.48%12.39M | -69.92%12.38M | -69.92%12.38M | -28.38%34.42M |
Non current accrued expenses | 74.67%1.22B | 74.04%1.18B | 74.96%1.16B | 74.96%1.16B | 7.16%708.33M | 5.98%697.36M | 3.10%677.77M | 0.74%660.55M | 0.74%660.55M | -0.16%660.99M |
Long term provisions | 87.20%692.15M | 85.69%654.95M | 61.53%611.31M | 61.53%611.31M | 8.10%392.65M | 12.56%369.74M | 9.82%352.72M | 23.66%378.45M | 23.66%378.45M | 7.59%363.24M |
Employee benefits | ---- | ---- | 62.33%21.36M | 62.33%21.36M | ---- | ---- | ---- | -24.87%13.16M | -24.87%13.16M | ---- |
Total non current liabilities | 96.17%1.25B | 94.66%1.21B | 76.64%1.19B | 76.64%1.19B | 5.20%669.43M | 7.34%634.69M | 5.80%623.8M | 14.01%673.59M | 14.01%673.59M | 3.99%636.31M |
Shareholders'equity | ||||||||||
Share capital | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | -3.55%229.46M | -6.93%229.46M | -7.08%229.46M | -7.08%229.46M | -7.03%229.46M |
-common stock | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | 0.00%229.46M | -3.55%229.46M | -6.93%229.46M | -7.08%229.46M | -7.08%229.46M | -7.03%229.46M |
Additional paid-in capital | -5.29%23.28M | -4.70%22.14M | -6.14%20.74M | -6.14%20.74M | -8.16%19.33M | -19.55%24.58M | -39.07%23.23M | -41.01%22.1M | -41.01%22.1M | -41.95%21.05M |
Gains losses not affecting retained earnings | 512.50%231K | -404.71%-1.1M | -233.01%-407K | -233.01%-407K | -389.00%-1.16M | -411.11%-56K | 5,257.14%361K | 15,200.00%306K | 15,200.00%306K | 6,766.67%400K |
Noncontrolling interests | -2.14%81.21M | -2.87%74.5M | 7.67%81.44M | 7.67%81.44M | 23.57%85.71M | 38.85%82.98M | 26.83%76.7M | 35.13%75.64M | 35.13%75.64M | 31.03%69.36M |
Total equity | 67.27%1.62B | 66.34%1.58B | 57.88%1.55B | 57.88%1.55B | 10.00%1.01B | 11.62%971.32M | 8.02%950.02M | 12.68%979.51M | 12.68%979.51M | 4.85%917.37M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.